Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth K Fletcher

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Circulation. Heart Failure|July 21, 2023
Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in MiceElizabeth K Fletcher, Njabulo Ngwenyama, Nga Nguyen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 3, 2020
Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting HemostasisLayla Van Doren, Nga Nguyen, Christopher Garzia, et al.
Analytical Chemistry|February 23, 2026
Prolonging Sample Stability with Machine Learning Expands the Catalog of Tests Available for Mail-In Capillary Blood Collected At-HomeConnor P O'Meara, Elizabeth K Fletcher, Alamgir Khan, et al.
The Journal of Investigative Dermatology|October 6, 2018
PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis ModelsTravis P Barr, Chris Garzia, Srijoy Guha, et al.
The Journal of Endocrinology|January 29, 2019
Cardiomyocyte transcription is controlled by combined mineralocorticoid receptor and circadian clock signallingELizabeth K Fletcher, Monica Kanki, James Morgan, et al.
Hepatology (Baltimore, Md.)|May 23, 2022
PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interferenceAndrew M Shearer, Yanling Wang, Elizabeth K Fletcher, et al.
Hypertension (Dallas, Tex. : 1979)|September 10, 2015
Cardiomyocyte Mineralocorticoid Receptor Activation Impairs Acute Cardiac Functional Recovery After Ischemic InsultLaura A Bienvenu, Melissa E Reichelt, James Morgan, et al.
Endocrinology|June 2, 2012
Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosisLaura A Bienvenu, James Morgan, Amanda J Rickard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2020
PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 StudyAthan Kuliopulos, Paul A Gurbel, Jeffrey J Rade, et al.
Molecular Metabolism|November 1, 2019
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver diseaseRajashree Rana, Andrew M Shearer, Elizabeth K Fletcher, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Circulation. Heart Failure|July 21, 2023
Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in MiceElizabeth K Fletcher, Njabulo Ngwenyama, Nga Nguyen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 3, 2020
Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting HemostasisLayla Van Doren, Nga Nguyen, Christopher Garzia, et al.
Analytical Chemistry|February 23, 2026
Prolonging Sample Stability with Machine Learning Expands the Catalog of Tests Available for Mail-In Capillary Blood Collected At-HomeConnor P O'Meara, Elizabeth K Fletcher, Alamgir Khan, et al.
The Journal of Investigative Dermatology|October 6, 2018
PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis ModelsTravis P Barr, Chris Garzia, Srijoy Guha, et al.
The Journal of Endocrinology|January 29, 2019
Cardiomyocyte transcription is controlled by combined mineralocorticoid receptor and circadian clock signallingELizabeth K Fletcher, Monica Kanki, James Morgan, et al.
Hepatology (Baltimore, Md.)|May 23, 2022
PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interferenceAndrew M Shearer, Yanling Wang, Elizabeth K Fletcher, et al.
Hypertension (Dallas, Tex. : 1979)|September 10, 2015
Cardiomyocyte Mineralocorticoid Receptor Activation Impairs Acute Cardiac Functional Recovery After Ischemic InsultLaura A Bienvenu, Melissa E Reichelt, James Morgan, et al.
Endocrinology|June 2, 2012
Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosisLaura A Bienvenu, James Morgan, Amanda J Rickard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2020
PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 StudyAthan Kuliopulos, Paul A Gurbel, Jeffrey J Rade, et al.
Molecular Metabolism|November 1, 2019
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver diseaseRajashree Rana, Andrew M Shearer, Elizabeth K Fletcher, et al.
Pageof 2